Clinical Research Directory
Browse clinical research sites, groups, and studies.
Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin
Sponsor: Rao Dermatology
Summary
The goal of this study is to visualize the deposition of topical 0.3% roflumilast (Zoryve) compared to vehicle using Line-Field Optical Coherence Tomography (LC-OCT) in vivo in healthy skin. We hypothesize that the application of topical 0.3% roflumilast (Zoryve) will result in distinct patterns of deposition within the epidermal and dermal layers compared to the vehicle. Specifically, we anticipate observing deeper penetration and more uniform distribution of roflumilast within the skin layers, indicative of enhanced efficacy, as visualized by LC-OCT imaging.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3
Start Date
2024-05-28
Completion Date
2024-07-28
Last Updated
2024-06-03
Healthy Volunteers
Yes
Conditions
Interventions
Roflumilast
Roflumilast 0.3% cream
Vehicle (Roflumilast 0.3% vehicle cream)
Vehicle (Roflumilast 0.3% vehicle cream)
Locations (1)
Rao Dermatology
Atlantic Highlands, New Jersey, United States